Durieu J, Wallaert B, Tonnel A B
Clinique de Maladies Respiratoires, Hôpital A. Calmette, Lille, France.
Eur Respir J. 1997 Feb;10(2):286-91. doi: 10.1183/09031936.97.10020286.
The prognosis of chronic eosinophilic pneumonia (CEP) is usually good under corticosteroid therapy (CST). The main complications are relapses when treatment is tapered or discontinued. The aim of this retrospective, multicentre study was to evaluate the long-term consequences of CEP on pulmonary function tests. Nineteen patients (mean +/- SEM age 51 +/- 16 yrs) with CEP were studied. Lung function tests were performed at the time of diagnosis and at follow-up, and included flow-volume curve. The results of the first pulmonary function test were normal in six patients, restrictive in nine, and obstructive in four. Relapses (recurrence of initial signs) occurred in nine patients. The last evaluation (mean +/- SEM follow-up of 49 +/- 44 months, range 12-142 months) showed a complete recovery in 8 of the 19 patients. One patient developed bilateral apical fibrosis. The remaining 10 patients, exhibited obstructive pulmonary function without relapse of CEP at this time. Bronchoalveolar lavage (BAL) eosinophilia at the time of the initial evaluation tended to be higher (p = 0.05) in these 10 patients than in those with normal pulmonary function findings at follow-up. This study demonstrates: firstly, that the development of an obstructive ventilatory defect is a common finding during the course of chronic eosinophilic pneumonia (CEP); secondly, that bronchial obstruction might appear despite the absence of clinical and radiological signs of relapse; and, thirdly, that a markedly increased bronchoalveolar lavage eosinophilia at the initial evaluation is associated with a higher risk of development of bronchial obstruction. These results suggest that pulmonary function tests should be included in the management of chronic eosinophilic pneumonia.
在皮质类固醇治疗(CST)下,慢性嗜酸性粒细胞性肺炎(CEP)的预后通常良好。主要并发症是在治疗逐渐减量或停药时复发。这项回顾性多中心研究的目的是评估CEP对肺功能测试的长期影响。研究了19例CEP患者(平均±标准误年龄51±16岁)。在诊断时和随访时进行肺功能测试,包括流量-容积曲线。首次肺功能测试结果,6例正常,9例为限制性通气功能障碍,4例为阻塞性通气功能障碍。9例患者出现复发(初始症状再次出现)。最后一次评估(平均±标准误随访49±44个月,范围12 - 142个月)显示,19例患者中有8例完全康复。1例患者出现双侧肺尖纤维化。其余10例患者此时表现为阻塞性肺功能,且CEP未复发。在这10例患者中,初始评估时支气管肺泡灌洗(BAL)嗜酸性粒细胞增多的程度往往高于随访时肺功能正常的患者(p = 0.05)。本研究表明:首先,阻塞性通气功能障碍的发生是慢性嗜酸性粒细胞性肺炎(CEP)病程中的常见表现;其次,即使没有临床和影像学复发迹象,也可能出现支气管阻塞;第三,初始评估时支气管肺泡灌洗嗜酸性粒细胞显著增加与支气管阻塞发生风险较高相关。这些结果表明,肺功能测试应纳入慢性嗜酸性粒细胞性肺炎的管理中。